0
Editorial |

Report Card on Molecular Genetic Testing:  Room for Improvement?

Wayne W. Grody, MD, PhD; Reed E. Pyeritz, MD, PhD
JAMA. 1999;281(9):845-847. doi:10.1001/jama.281.9.845.
Text Size: A A A
Published online

Extract

Few areas of medicine are evolving as rapidly as molecular testing, and virtually no area holds so much promise for altering the practice of medicine. Of course, testing based on molecules has been conducted from at least the time when physicians tasted urine to detect glycosuria. Today multiparameter automated chemical analyzers have greatly extended the ability to test for hundreds of compounds in any sample of the human body. But the term molecular genetic testing now refers specifically to nucleic acid analysis, usually involving DNA. The techniques have become so sophisticated and numerous that increasingly the average physician can have no more understanding of molecular genetic testing than of the inner workings of the instrument that performs a chem-18. However, several points warrant emphasis: the scope and impact of molecular testing continue to expand, organized medicine must ensure the highest quality of the molecular testing process, and what comes before and after most molecular tests (the preanalytic and postanalytic aspects) are often just as important as the test itself and do involve a health professional, often a physician, to a high degree.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 8

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs